Cervical dilation before first-trimester surgical abortion (<14 weeks' gestation)

被引:33
作者
Allen, Rebecca H. [1 ]
Goldberg, Alisa B. [2 ]
机构
[1] Brown Univ, Women & Infants Hosp, 101 Dudley St, Providence, RI 02905 USA
[2] Harvard Univ, Sch Med, Planned Parenthood League Massachusetts, 1055 Commonwealth Ave, Boston, MA 02215 USA
关键词
Surgical abortion; Cervical dilation; Laminaria; Misoprostol; Dilapan; Pain; 1ST TRIMESTER ABORTION; RANDOMIZED-CONTROLLED-TRIAL; MANUAL VACUUM ASPIRATION; LEGAL INDUCED-ABORTION; NITRIC-OXIDE RELEASE; 200; MU-G; VAGINAL MISOPROSTOL; ORAL MISOPROSTOL; LAMINARIA TENTS; PREGNANCY INTERRUPTION;
D O I
10.1016/j.contraception.2015.12.001
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
First-trimester surgical abortion is a common, safe procedure with a major complication rate of less than 1%. Cervical dilation before suction abortion is usually accomplished using tapered mechanical dilators. Risk factors for major complications in the first trimester include increasing gestational age and provider inexperience. Cervical priming before first-trimester surgical abortion has been studied using osmotic dilators and pharmacologic agents, most commonly misoprostol. Extensive data demonstrate that a variety of agents are safe and effective at causing preoperative cervical softening and dilation; however, given the small absolute risk of complications, the benefit of routine use of misoprostol or osmotic dilators in first-trimester surgical abortion is unclear. Although cervical priming results in reduced abortion time and improved provider ease, it requires a delay of at least 1 to 3 h and may confer side effects. The Society of Family Planning does not recommend routine cervical priming for first-trimester suction abortion but recommends limiting consideration of cervical priming for women at increased risk of complications from cervical dilation, including those late in the first trimester, adolescents and women in whom cervical dilation is expected to be challenging. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:277 / 291
页数:15
相关论文
共 158 条
[1]  
Acharya PS, 1999, CLIN INFECT DIS, V29, P695, DOI 10.1086/598666
[2]   SAFETY OF LOCAL-ANESTHESIA AND OUTPATIENT TREATMENT - CONTROLLED-STUDY OF INDUCED-ABORTION BY VACUUM ASPIRATION [J].
ANDOLSEK, L ;
CHENG, M ;
HREN, M ;
OGRINCOVEN, M ;
NG, A ;
RATNAM, S ;
BELSEY, M ;
EDSTROM, K ;
HEINER, P ;
KINNEAR, K ;
TIETZE, C .
STUDIES IN FAMILY PLANNING, 1977, 8 (05) :118-124
[3]  
[Anonymous], 1981, CONTRACEPTION, V23, P251
[4]  
[Anonymous], 2009, MANAGEMENT UNINTENDE, DOI DOI 10.1002/9781444313031
[5]   Sublingual compared with oral misoprostol for cervical dilatation prior to vacuum aspiration:: a randomized comparison [J].
Aronsson, A ;
Helström, L ;
Gemzell-Danielsson, K .
CONTRACEPTION, 2004, 69 (02) :165-169
[6]   Effects of misoprostol on uterine contractility following different routes of administration [J].
Aronsson, A ;
Bygdeman, M ;
Gemzell-Danielsson, K .
HUMAN REPRODUCTION, 2004, 19 (01) :81-84
[7]   Mifepristone versus vaginally administered misoprostol for cervical priming before first-trimester termination of pregnancy: A randomized, controlled study [J].
Ashok, PW ;
Flett, GMM ;
Templeton, A .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2000, 183 (04) :998-1002
[8]   Randomised controlled study comparing oral and vaginal misoprostol for cervical priming prior to surgical termination of pregnancy [J].
Ashok, PW ;
Hamoda, H ;
Nathani, F ;
Flett, GMM ;
Templeton, A .
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2003, 110 (12) :1057-1061
[9]  
Baldock S., 2006, COMMUNICATION
[10]   Risk factors for legal induced abortion-related mortality in the United States [J].
Bartlett, LA ;
Berg, CJ ;
Shulman, HB ;
Zane, SB ;
Green, CA ;
Whitehead, S ;
Atrash, HK .
OBSTETRICS AND GYNECOLOGY, 2004, 103 (04) :729-737